News

Novatus Global Raises $40 Million for Global Expansion and Tech

Novatus Global Raises $40 Million for Global Expansion and Tech

Novatus Global Secures Major Investment for Future Growth

Novatus Global Limited, a leading provider of regulatory technology solutions for financial institutions, has successfully raised $40 million from Silversmith Capital Partners, a growth equity firm based in Boston. This investment is a significant boost for Novatus as it sets out to enhance its regulatory services, expand its international footprint, and strengthen its position in the market.

Transforming Regulatory Technology

Established in 2019, Novatus has quickly built a solid reputation by delivering innovative regulatory solutions to major banks and financial institutions across the globe. With revenues more than tripling in the past year, the company plans to use this fresh influx of capital to further its technological advancements. This funding will enable Novatus to broaden its geographic presence and continuously enhance its top-notch SaaS platform.

Improving Regulatory Compliance with Cutting-Edge Solutions

Novatus’s flagship product, Novatus En:ACT, is an exceptional SaaS platform that excels at navigating the complexities of global regulations. It provides clients with precise and timely reporting capabilities, which are crucial for meeting compliance obligations in various jurisdictions. This cloud-native platform allows businesses to efficiently reconcile multiple source systems and submission files required for G20 transaction reporting.

Advisory Services to Overcome Compliance Challenges

Beyond its technological capabilities, Novatus offers expert-led advisory services that capitalize on the company’s industry knowledge. This assistance helps clients of all sizes tackle their unique compliance challenges, particularly in areas such as risk management and ESG initiatives. Novatus is dedicated to empowering financial institutions to effectively address their regulatory hurdles.

Strategic Goals and Future Growth

Reflecting on the investment, Andrew Hedley, Co-Founder and Partner of Novatus, expressed excitement about the partnership with Silversmith. He noted that this funding will not only drive their commitment to innovation but also support their expansion efforts in new markets, especially in North America, following their successful entry into Australia.

Understanding the Unique Market Position

Matthew Ranson, another Co-Founder and Partner, shared insights into the origins of Novatus’s approach. After experiencing the challenges of transaction reporting themselves, they aimed to create solutions that minimize the need for human intervention through automation. The partnership with Silversmith enhances this vision, further establishing their unique position in the regulatory technology field, particularly with the incorporation of AI and machine learning.

Appreciating the Support from Investors

Ned Kingsley, Principal at Silversmith, emphasized the firm’s investment philosophy focused on backing outstanding founders. They see the transformative work that Andrew and Matt are doing at Novatus and believe in their potential to significantly change transaction reporting.

Future Collaborations and Board Enhancements

With this new capital injection, Silversmith’s Todd MacLean and Ned Kingsley will join Novatus’s Board of Directors. This collaboration aims to foster further progress in Novatus's offerings and support its overall growth. Existing investors, including Maven Capital Partners, continue to play an active role in nurturing Novatus as it grows and scales its operations worldwide.

About Novatus Global Limited

Founded in 2019, Novatus Global dedicates itself to helping large financial institutions navigate the complex regulatory landscape. Their award-winning Novatus En:ACT platform ensures precise reporting aligned with a variety of global regulations while promoting operational excellence and compliance. By merging innovative technology with in-depth industry knowledge, they position their clients for sustainable growth.

About Silversmith Capital Partners

Silversmith Capital Partners, established in 2015, is focused on partnering with visionary entrepreneurs in the technology and healthcare sectors. With over $3.3 billion managed, they aim to build businesses that address real customer challenges and place them on a path to long-term success. Their experience in nurturing high-growth companies like Novatus showcases their dedication to driving significant change in the marketplace.

Frequently Asked Questions

What is the purpose of Novatus's $40 million investment?

The investment is intended to enhance Novatus's regulatory solutions and expand its market presence, especially in North America.

What is the main product offered by Novatus?

Novatus’s primary offering is the Novatus En:ACT platform, a SaaS solution crafted for accurate transaction reporting and regulatory compliance.

Who are the notable investors in Novatus?

Silversmith Capital Partners and Maven Capital Partners are key investors supporting Novatus’s growth initiatives.

What notable changes has Novatus undergone recently?

Recently, Novatus has experienced a significant revenue increase, tripling over the past year, driven by growing demand for its regulatory solutions.

What role will the new board members fulfill?

Todd MacLean and Ned Kingsley will join Novatus’s Board to guide the company as it navigates its growth trajectory and implements its strategic initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Alphabet Surprises with Strong Earnings, Stocks React Mixed

Updated Category News Views 160

Market Overview: Nasdaq Decline and Mixed Results U.S. stocks experienced a mixed trading session, with the Nasdaq Composite registering a notable drop of over 1% recently. The trading began with the Dow Jones Industrial Average slightly up by 0.03%, reaching 47,644.08, while the Nasdaq decreased by 1.13% to settle at 23,687.37. Similarly, the S&P 500 index fell by 0.63%,...

Continue Reading
FTI Consulting Welcomes Antitrust Expert Dr. William Rogerson

Updated Category News Views 261

FTI Consulting Expands Expertise with Dr. William Rogerson In an exciting move, FTI Consulting, Inc. (NYSE: FCN) has announced that Dr. William Rogerson has joined its subsidiary Compass Lexecon, marking a significant enhancement to their consulting capabilities, especially in the arenas of competition and antitrust. About Dr. William Rogerson Dr. Rogerson is renowned for...

Continue Reading
Coop Pank's July 2025 Financial Insights and Growth Strategies

Updated Category News Views 217

Coop Pank’s Impressive Financial Performance In July 2025, Coop Pank demonstrated remarkable growth in its client base and financial metrics. With an increase of 1,700 clients, the total number of bank clients reached 219,300, while active clients grew by 600 to a total of 104,100. This 11% increase in the customer base over the year highlights the bank’s successful...

Continue Reading
Gordon Johnson Labels Crypto Market as Corrupt Amid Trump Plan

Updated Category News Views 289

Gordon Johnson Criticizes Market Integrity Gordon Johnson, an analyst at GLJ Research, recently made headlines with his statements on the cryptocurrency market. He expressed concerns over what he described as rampant market 'corruption' following President Donald Trump’s announcement regarding a strategic U.S. cryptocurrency reserve. This reserve is set to include...

Continue Reading
Custom Veterinary and Green Mountain Join Forces for Pet Wellness

Updated Category News Views 252

Custom Veterinary Joins Forces with Green Mountain Animal Custom Veterinary Services, a platform supported by Align Capital Partners, has taken a significant step in the pet health industry by acquiring Green Mountain Animal, LLC. This strategic acquisition marks a pivotal moment for both companies as they look to enhance their offerings and services in the pet health...

Continue Reading